We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$377M
AUM Growth
-$1.21M
Cap. Flow
-$8.07M
Cap. Flow %
-2.14%
Top 10 Hldgs %
64.66%
Holding
168
New
29
Increased
45
Reduced
51
Closed
28

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$2.22M
2
CL icon
Colgate-Palmolive
CL
+$1.39M
3
ABT icon
Abbott
ABT
+$1.11M
4
CI icon
Cigna
CI
+$945K
5
BAX icon
Baxter International
BAX
+$738K

Top Sells

Rank Stock Value
1
VNQ icon
Vanguard Real Estate ETF
VNQ
+$3.37M
2
MSFT icon
Microsoft
MSFT
+$2.29M
3
AAPL icon
Apple
AAPL
+$1.72M
4
ADM icon
Archer Daniels Midland
ADM
+$1.56M
5
ECL icon
Ecolab
ECL
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 12%
3 Consumer Staples 4.93%
4 Communication Services 2.82%
5 Materials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
51
Boston Scientific
BSX
$71.5B
$1.02M 0.27%
13,263
+2,598
+24% +$190K
GILD icon
52
Gilead Sciences
GILD
$165B
$1M 0.27%
14,637
+1,116
+8% +$74.5K
JPM icon
53
JPMorgan Chase
JPM
$950B
$976K 0.26%
4,824
+1,038
+27% +$203K
FMC icon
54
FMC
FMC
$1.33B
$972K 0.26%
16,889
-6,544
-28% -$391K
REGN icon
55
Regeneron Pharmaceuticals
REGN
$80.8B
$960K 0.25%
913
-61
-6% -$59.1K
CMCSA icon
56
Comcast
CMCSA
$90B
$941K 0.25%
24,021
-830
-3% -$32.5K
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$126B
$909K 0.24%
1,939
-89
-4% -$38.6K
AMZN icon
58
Amazon
AMZN
$2.96T
$870K 0.23%
4,504
-6,371
-59% -$1.17M
DGX icon
59
Quest Diagnostics
DGX
$26.3B
$827K 0.22%
6,039
+1,008
+20% +$138K
AGCO icon
60
AGCO
AGCO
$7.2B
$812K 0.22%
8,293
-1,400
-14% -$156K
DHR icon
61
Danaher
DHR
$144B
$780K 0.21%
3,123
-670
-18% -$169K
BAC icon
62
Bank of America
BAC
$442B
$740K 0.2%
18,609
+7,436
+67% +$285K
MCK icon
63
McKesson
MCK
$101B
$708K 0.19%
1,212
+42
+4% +$23.4K
CVS icon
64
CVS Health
CVS
$122B
$682K 0.18%
11,555
+7,505
+185% +$469K
SJM icon
65
J.M. Smucker
SJM
$12.8B
$671K 0.18%
+6,158
New +$697K
IQV icon
66
IQVIA
IQV
$39.3B
$663K 0.18%
3,136
+2,030
+184% +$461K
INGR icon
67
Ingredion
INGR
$6.58B
$651K 0.17%
5,672
+1,728
+44% +$200K
IBB icon
68
iShares Biotechnology ETF
IBB
$9.77B
$618K 0.16%
4,500
– –
DMC
69
Del Monte Corp
DMC
$1.45B
$613K 0.16%
28,069
+13,905
+98% +$334K
ELV icon
70
Elevance Health
ELV
$85.5B
$609K 0.16%
1,124
-190
-14% -$100K
ZBH icon
71
Zimmer Biomet
ZBH
$18.4B
$599K 0.16%
5,515
+1,762
+47% +$208K
WFC icon
72
Wells Fargo
WFC
$264B
$568K 0.15%
9,567
+1,250
+15% +$73.8K
C icon
73
Citigroup
C
$226B
$567K 0.15%
+8,931
New +$551K
TMUS icon
74
T-Mobile US
TMUS
$190B
$565K 0.15%
3,207
-283
-8% -$47.5K
HD icon
75
Home Depot
HD
$355B
$519K 0.14%
1,507
-682
-31% -$233K
1 2
3
4 5

Similar funds

MWM
Momentous Wealth Management Vancouver, Washington $175M AUM 14.91% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return
CC
Converium Capital Montreal $175M AUM
BW
Basepoint Wealth Cedar Rapids, Iowa $175M AUM 43.04% 1-Year Est. Return
DWA
Delos Wealth Advisors Dallas, Texas $175M AUM 19.35% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Humankind Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Humankind Investments held 168 positions worth $377M, down 0.32% from $378M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Humankind Investments's Q2 2024 filing shows 29 new, 45 increased, 51 reduced and 28 closed positions. Its largest new stake was Intel: 67,783 shares worth $2.1M. The largest sale was Vanguard Real Estate ETF, an estimated $3.37M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Humankind Investments's largest Q2 2024 buy was Intel: 67,783 shares worth $2.1M.
  • Humankind Investments added most to Colgate-Palmolive in Q2 2024, an estimated $1.39M increase.
  • Humankind Investments's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.29M.
  • Humankind Investments fully exited Vanguard Real Estate ETF in Q2 2024, selling an estimated $3.37M.
  • Humankind Investments's ten largest holdings make up 65% of its $377M portfolio in Q2 2024.
  • Humankind Investments opened 29 new positions and closed 28 in Q2 2024.
  • Humankind Investments's portfolio value fell 0.32% quarter-over-quarter to $377M.

Based on Humankind Investments's 13F filing for Q2 2024, filed 12 Aug 2024.